Further, CXCR2 antagonist treatment significantly reduced MDSC infiltration in CRC tissues (Figure 6K,L), which was accompanied by enhanced T cell infiltration (Figure S9E, Supporting Information). This evidence concerns the gene CXCR2 and colorectal carcinoma.